9270-25-R-RFIN-00013

The University of Mississippi's Department of Pharmaceutics and Drug Delivery is seeking to procure a Styl' One Nano Compaction Simulator through a sole source procurement from KORSCH America, Inc. This specialized laboratory equipment will be used to simulate full-scale pharmaceutical tablet manufacturing for graduate research projects and the department's Hands-on Course in Tablet Technology. The procurement is specifically focused on acquiring a unique piece of equipment that can simulate commercial tablet production in a compact laboratory setting, with KORSCH being identified as the only provider of such laboratory-scale technology. Interested parties may submit objections to the sole source certification until Tuesday, February 11, 2025, at 10:00 am Central Time, with contact options available through the university's procurement services. The university has already negotiated a 23% discount on the project total, with KORSCH agreeing to provide additional value through training opportunities for graduate students and course attendees. The primary objectives include enhancing the department's research capabilities, improving grant and contract acquisition potential, and providing advanced training in pharmaceutical tablet technology. Evaluation appears to be based on the unique capabilities of the equipment and its alignment with the department's educational and research goals.

No specific set-aside designations or restrictions on responding organizations are explicitly mentioned in the documentation. The procurement appears to be a direct purchase by the University of Mississippi, with KORSCH America, Inc. as the sole source vendor. The estimated value of the procurement is not directly stated, though the documents suggest the equipment would typically cost 2-3 times more in a pilot-scale configuration. The university has emphasized the cost-effectiveness of this particular solution, noting that the Styl' One Nano Compaction Simulator is more appropriately sized for their existing laboratory space compared to larger pilot-scale alternatives. KORSCH America, Inc. will be the primary vendor, with an added benefit of providing training and supporting the university's educational objectives. The procurement represents a strategic investment in pharmaceutical research and education infrastructure, with potential long-term benefits for student training and research capabilities. No information is provided about alternative vendors or incumbent contractors for similar equipment.